COMMUNIQUÉS West-GlobeNewswire

Spero Therapeutics Highlights SPR994 Data at the 29th European Congress of Clinical Microbiology and Infectious Diseases
08/04/2019
Five presentations on SPR994 and cUTI resistance trends at ECCMID provide support for Phase 3 program and unmet need CAMBRIDGE, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi- [...]
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS)
08/04/2019
– New Allowance by U.S. Patent and Trademark Office Includes irritable bowel syndrome (IBS) test kit panel – IRVINE, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced today that the [...]
Auransa to Participate in BioCentury's 26th Annual Future Leaders in the Biotech Industry Conference
08/04/2019
PALO ALTO, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical need, today announced [...]
Managers’ transactions
08/04/2019
Company announcement No. 7/2019 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 About Chr. Hansen [...]
REPEAT - RavenQuest Secures Health Canada Cultivation License at Edmonton Facility
08/04/2019
VANCOUVER, British Columbia, April 08, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “ Company ” or “ RavenQuest ”) a federally-licensed producer of cannabis, is pleased to [...]
IntelGenx to Promote VetaFilm™ Oral Film Technology at Human Biotech & Animal Health Business Partnering Summit
08/04/2019
SAINT LAURENT, Quebec, April 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it will promote its proprietary VetaFilm™ oral [...]
Daré Bioscience Announces Publication of Pharmacokinetics Study of DARE-HRT1, a Potential Hormone Replacement Therapy, in the Journal of Pharmaceutical Sciences
08/04/2019
SAN DIEGO, April 08, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the article entitled “Pharmacokinetics and tolerability of a novel 17β-estradiol [...]
Opiant Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Data Supporting Potential of OPNT003, Nasal Nalmefene, for Treatment of Synthetic Opioid Overdose
08/04/2019
Data published online in the Journal of Pharmacology and Experimental Therapeutics SANTA MONICA, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a specialty pharmaceutical company [...]
Kaleido Biosciences Announces Key Appointments to Leadership Team
08/04/2019
Johan van Hylckama Vlieg, Ph.D., Named Chief Scientific Officer and Clare Fisher Appointed Chief Business Officer LEXINGTON, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc . (Nasdaq: KLDO), a [...]
HealthLynked Announces the Addition of Richard Williamson as New VP of Marketing
08/04/2019
NAPLES, Fla., April 08, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp ( OTCQB: HLYK ) (the “Company”), a leader in digital healthcare technology, today announced the appointment of Richard Williamson as Vice President of [...]
Cue Biopharma to Present Immuno-STAT Platform Technology at PEGs Boston 2019
08/04/2019
CAMBRIDGE, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc. (NASDAQ: CUE), an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the [...]
TYME’s SM-88 First Human Study in Patients with Metastatic Cancer Published in the Journal, Investigational New Drugs
08/04/2019
New oral approach aimed at disrupting cancer metabolism SM-88 is an investigational Cancer Metabolism-Based Therapy (CMBTs TM ) that has demonstrated responses across 15 different cancers 30 patients enrolled in study [...]
Profound Medical Analyst & Investor Day Agenda
08/04/2019
TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic [...]
PDS Biotechnology Appoints Stephen Glover to its Board of Directors
08/04/2019
BERKELEY HEIGHTS, N.J., April 08, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immuno-oncology company developing novel multifunctional immunotherapeutic products, today [...]
PotNetwork News Signs on as Media Sponsor for Cannabis World Congress and Business Expo and CBD Expo Tour
08/04/2019
The industry's leader for marijuana news and information brings its successful live broadcasts to two of the top tradeshows in the entrepreneurial cannabis space MIAMI, April 08, 2019 (GLOBE NEWSWIRE) -- PotNetwork News [...]
MediPharm Labs Assembles Globally Renowned Experts to Form Scientific Advisory Committee
08/04/2019
TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]
Oncology Venture invites to a webcast April 8 at 16:30
08/04/2019
Investor News Following the presentation of Oncology Venture’s prospectus as part of the rights issue announced on Friday, April 5, the company invites to a webcast. At the webcast, Oncology Venture’s CEO Peter Buhl [...]
Melinta Therapeutics Announces Multiple Presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
08/04/2019
~ Presentations and Posters Highlight New Data from Antibiotics Portfolio ~ MORRISTOWN, N.J., April 08, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the [...]
VitalHub Announces Licensing of Patient Flow Solution to Leading Middle East Hospital
08/04/2019
TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that it has licensed its MCAP patient flow software solution to Hamad Medical Corporation (“HMC [...]

Pages